Qingsong Liu

发表

Resolution analysis of focused plenoptic camera with four types focal lengths

Jun Li, Yan Wang, Shaojun Du, 2019, Applied Optics and Photonics China.

Gemcitabine and Chk1 Inhibitor AZD7762 Synergistically Suppress the Growth of Lkb1-Deficient Lung Adenocarcinoma.

Yan Liu, Feiyang Liu, Peng Gao, 2017, Cancer research.

Chaperones as thermodynamic sensors of drug–target interactions reveal kinase inhibitor specificities in living cells

Sandro Santagata, Susan Lindquist, Luke Whitesell, 2013, Nature Biotechnology.

Discovery and structural analysis of Eph receptor tyrosine kinase inhibitors.

Nathanael S Gray, Qingsong Liu, N. Gray, 2009, Bioorganic & medicinal chemistry letters.

Developing irreversible inhibitors of the protein kinase cysteinome.

Nathanael S Gray, Qingsong Liu, Zheng Zhao, 2013, Chemistry & biology.

Moderate intensity static magnetic fields affect mitotic spindles and increase the antitumor efficacy of 5-FU and Taxol.

Wenchao Wang, Wei Chen, Xinmiao Ji, 2016, Bioelectrochemistry.

Inhibitor-sensitive FGFR2 and FGFR3 mutations in lung squamous cell carcinoma.

Chandra Sekhar Pedamallu, Gad Getz, Kwok-Kin Wong, 2013, Cancer research.

Discovery of (R)-1-(3-(4-Amino-3-(3-chloro-4-(pyridin-2-ylmethoxy)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one (CHMFL-EGFR-202) as a Novel Irreversible EGFR Mutant Kinase Inhibitor with a Distinct Binding Mode.

Jing Liu, Cheng Chen, Wei Wang, 2017, Journal of medicinal chemistry.

The ALK(F1174L) mutation potentiates the oncogenic activity of MYCN in neuroblastoma.

Bandana Sharma, Wenchao Wang, Nathanael S Gray, 2012, Cancer cell.